Skip to main content
bluebird bio, Inc. (BLUE)
Jun 2, 2025 - BLUE was delisted (reason: acquired by Carlyle and SK Capital)
4.970
0.00 (0.00%)
Inactive · Last trade price on May 30, 2025

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Gene Therapies
29.07M
Log In
Log In
Log In
Log In
Upgrade
Gene Therapies Growth
961.15%
Log In
Log In
Log In
Log In
Upgrade
Other
432.00K
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-49.65%
Log In
Log In
Log In
Log In
Upgrade
Collaborative Arrangement
-
Log In
Log In
Log In
Log In
Upgrade
Royalty and Other
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
United States
29.50M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
720.04%
Log In
Log In
Log In
Log In
Upgrade